CN110250417A - For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material - Google Patents
For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material Download PDFInfo
- Publication number
- CN110250417A CN110250417A CN201910585656.7A CN201910585656A CN110250417A CN 110250417 A CN110250417 A CN 110250417A CN 201910585656 A CN201910585656 A CN 201910585656A CN 110250417 A CN110250417 A CN 110250417A
- Authority
- CN
- China
- Prior art keywords
- bitter buckwheat
- fermentation
- buckwheat
- fermentation material
- bitter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000219051 Fagopyrum Species 0.000 title claims abstract description 197
- 235000009419 Fagopyrum esculentum Nutrition 0.000 title claims abstract description 197
- 238000000855 fermentation Methods 0.000 title claims abstract description 99
- 230000004151 fermentation Effects 0.000 title claims abstract description 91
- 239000000463 material Substances 0.000 title claims abstract description 42
- 208000001145 Metabolic Syndrome Diseases 0.000 title claims abstract description 25
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 235000013305 food Nutrition 0.000 title claims abstract description 19
- 235000013361 beverage Nutrition 0.000 title claims abstract description 14
- 238000009835 boiling Methods 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 23
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 18
- 239000006041 probiotic Substances 0.000 claims abstract description 15
- 235000018291 probiotics Nutrition 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 51
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 51
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 51
- 235000005493 rutin Nutrition 0.000 claims description 51
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 51
- 229960004555 rutoside Drugs 0.000 claims description 51
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 10
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- 230000003442 weekly effect Effects 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- 241000228197 Aspergillus flavus Species 0.000 abstract description 25
- 235000019658 bitter taste Nutrition 0.000 abstract description 13
- 206010020772 Hypertension Diseases 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 230000005251 gamma ray Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 46
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 36
- 235000005875 quercetin Nutrition 0.000 description 24
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 23
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 23
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 23
- 229960001285 quercetin Drugs 0.000 description 23
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 230000036772 blood pressure Effects 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 102000004157 Hydrolases Human genes 0.000 description 13
- 108090000604 Hydrolases Proteins 0.000 description 13
- 230000008569 process Effects 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 108010068370 Glutens Proteins 0.000 description 5
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229930195730 Aflatoxin Natural products 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000005409 aflatoxin Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 244000130270 Fagopyrum tataricum Species 0.000 description 3
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- KPRZOPQOBJRYSW-UHFFFAOYSA-N o-hydroxybenzylamine Natural products NCC1=CC=CC=C1O KPRZOPQOBJRYSW-UHFFFAOYSA-N 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- -1 rue Glucoside Chemical class 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000001228 trophic effect Effects 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- ZBCATMYQYDCTIZ-UHFFFAOYSA-N 4-methylcatechol Chemical compound CC1=CC=C(O)C(O)=C1 ZBCATMYQYDCTIZ-UHFFFAOYSA-N 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- KQJSQWZMSAGSHN-UHFFFAOYSA-N (9beta,13alpha,14beta,20alpha)-3-hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(O)=C2C KQJSQWZMSAGSHN-UHFFFAOYSA-N 0.000 description 1
- BUWZJWAQZANSHV-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)ethanimidamide Chemical compound NC(=N)CC1=CC=C(O)C(O)=C1 BUWZJWAQZANSHV-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- FVMDYYGIDFPZAX-UHFFFAOYSA-N 3-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=CC(O)=C1 FVMDYYGIDFPZAX-UHFFFAOYSA-N 0.000 description 1
- PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylcatechol Chemical compound CC1=CC=CC(O)=C1O PGSWEKYNAOWQDF-UHFFFAOYSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- YNXLOPYTAAFMTN-SBUIBGKBSA-N C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 YNXLOPYTAAFMTN-SBUIBGKBSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- AQKDBFWJOPNOKZ-UHFFFAOYSA-N Celastrol Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(=O)C2C AQKDBFWJOPNOKZ-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010088847 Peptide YY Proteins 0.000 description 1
- 102100029909 Peptide YY Human genes 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- 240000000203 Salix gracilistyla Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- KQJSQWZMSAGSHN-JJWQIEBTSA-N celastrol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)[C@](C)(C(O)=O)CC[C@]1(C)CC[C@]2(C)C4=CC=C1C3=CC(=O)C(O)=C1C KQJSQWZMSAGSHN-JJWQIEBTSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a kind of bitter buckwheat fermentation material for preventing and treating metabolic syndrome, food or beverage and preparation method comprising the fermentation material, the preparation method of bitter buckwheat fermentation material is the following steps are included: it is 3-5% or warp that (1), which dries bitter buckwheat seed at 65-75 DEG C to water content,60The sterilizing of Co- gamma-ray irradiation;(2) bitter buckwheat seed obtained by step (1) is crushed, obtains buckwheat powder;Or impregnate bitter buckwheat seed in water, then boiling, obtain boiling bitter buckwheat seed;(3) buckwheat powder and water are mixed, saccharomycete is added and ferments, bitter buckwheat fermentation material is made;Or mix boiling bitter buckwheat seed, probiotics, saccharomycete, distiller's yeast and cold boiled water, it is sealed fermentation, bitter buckwheat fermentation material is made.Bitter buckwheat fermentation material obtained can effectively reduce bitter taste, improve the mouthfeel of bitter buckwheat product, improves bitter buckwheat fermentation quality and prevents Aspergillus flavus from generating, while can also prevent and treat hypertension, diabetes and fat this kind of metabolic syndrome.
Description
Technical field
The invention belongs to bitter buckwheat processing technique fields, and in particular to a kind of bitter buckwheat fermentation for preventing and treating metabolic syndrome
Object, the food or beverage comprising the fermentation material and preparation method.
Background technique
The whole world there are about 20%~25% world adult population with metabolic syndrome (Metabolic syndrome,
MS), MS has become a kind of global public health problem.MS includes diabetes, disorders of lipid metabolism (obesity) and hypertension.
MS pathogenesis is sufficiently complex, is not currently fully understood, it is considered that it is codetermined by environment and genetics factor.No
The eating habit and life style of health are the important environmental factors that MS occurs, thus caused obesity, insulin resistance, glycolipid
The illnesss such as metabolic disorder and hypertension are to cause the basis of MS.
Bitter buckwheat, bitter buckwheat rich in flavones, vitamin, polyphenol, terpene, carrotene and some other Phytochemistry function at
Part, have and adjusts pH value, growth of probiotics is promoted to improve function of intestinal canal;It improves insulin sensitivity, increase the prevention of intestinal juice viscosity
Glucose diffusion reduces by 2 diabetes risk of Type;Generating short chain fatty acids inhibits cholesterol biosynthesis to reduce cardiovascular disease
Risk;Promote intestines peristalsis shorten carcinogenic substance and body time of contact, balance female hormone (breast cancer, colorectal cancer, gastric cancer,
Oophoroma, prostate cancer) reduce risk of developing cancer;Fermentation generates hyperinsulinism sample peptide and Peptide YY, increases satiety and reduces
Energy intaking, leptin enhanced sensitivity consumption body fat control weight are conducive to the functions such as weight-reducing.Rutin, Rutin, also known as rue
Glucoside, citrin are bitter buckwheat flavone class compound main ingredient, can be used as edible antioxidant and nutrition enhancer etc..One molecule
Rutin hydrolyzes through rutin sophorin glycosidase rutin (osid) ase and generates a molecule rhamnose, glucose and Quercetin, i.e. Quercetin
It is the aglycon of rutin, Quercetin is only the function composition that rutin plays bioactivity in vivo.A large number of studies show that bitter buckwheat flavone is small
Molecular compound rutin is the most important function composition of advantageous human health.Rutin (rutin) has anti-inflammatory, inhibition aldose reductase
It is acted on citrin sample, but since it is practically insoluble in water, and fat-soluble also very little, is difficult to absorb in vivo after oral.Cause
This, the bioavilability for taking orally rutin or buck-wheat products rutin is very low, seriously limits the performance of bitter buckwheat rutin functional activity.Reed
Fourth can be converted into various compounds by intestinal flora, including various Quercetins and phenol derivatives, such as 3,4- dihydroxyphenyl second
Acid (DHPAA), 3,4- dihydroxytoluene (DHT), 3- hydroxyl phenylacetic acid (HPAA), 4- hydroxy 3-methoxybenzene acetic acid (Gao Xiangcao
Acid, vanillic acid);These interior metabolism products of rutin can effectively be absorbed by the body utilization, inhibit protein glycosylation, to sugar
The prevention and treatment of urine disease, hypertension and obesity have obvious effects on.
It for bitter buckwheat, drinks tartary buckwheat tea and can not drink health, because the function nutrition ingredient of bitter buckwheats is all including rutin etc.
It is insoluble in water, although being dissolved in boiling water, solubility is also very low, moreover people can not drink boiling water.Therefore health of the bitter buckwheat to people
It eats and.Eat how much the amount of being the problem of, how eating the nutritious bitter buckwheat food research and development that is only will primarily solve the problems, such as.Because of hardship
Buckwheat does not contain glutelin (being commonly called as gluten), causes to ferment as long patent flour, low content Tartary buckwheat noodles are not easily molded, easy
Fracture, the Tartary buckwheat noodles bitter buckwheat content of commercial type can reach 50% limit in 10%~30%, only only a few at present,
Under conditions of this " amount ", bitter buckwheat is almost that cannot bring into play to the alimentary health-care function of human body.
Buckwheat process is food processing industry " jewel on imperial crown ".The bitter taste for reducing bitter buckwheat improves its mouthfeel, improves fermentation
Quality and prevent Aspergillus flavus generate be bitter buckwheat processing key technology.So far, there is not yet the report of pertinent literature and patent.
Summary of the invention
For above-mentioned deficiency in the prior art, the bitter buckwheat that the present invention provides a kind of for preventing and treating metabolic syndrome ferments
Object, the food or beverage comprising the fermentation material and preparation method, the fermentation material can effectively reduce bitter buckwheat bitter taste, improve bitter buckwheat product
Mouthfeel, improving bitter buckwheat fermentation quality and prevents Aspergillus flavus from generating.
To achieve the above object, the technical solution adopted by the present invention to solve the technical problems is:
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) rutin hydrolase inactivates: it is 3-5% or warp that bitter buckwheat seed, which is dried at 65-75 DEG C to water content,60Co- γ is penetrated
Line irradiation sterilization, inactivates rutin hydrolase;
(2) fermented pretreatment: bitter buckwheat seed obtained by step (1) is crushed, buckwheat powder is obtained;Or it will be obtained by step (1)
Bitter buckwheat seed drains surface moisture, then boiling 30-40min after impregnating 4-20h in water, is then dried in the air naturally to room temperature, obtains boiling
Bitter buckwheat seed;
(3) it ferments: being by weight that 1:1-3 is mixed by buckwheat powder and water, the yeast of 2-4% buckwheat powder weight is then added
Bacterium mixes, and in 20-35 DEG C of fermentation 1-3h, bitter buckwheat fermentation material is made;Or by boiling bitter buckwheat seed, probiotics, saccharomycete, distiller's yeast
Mixed with cold boiled water, be sealed fermentation, fermentation temperature is 15-35 DEG C, first ferment 2-4 weeks to alcoholic strength be 3-5 degree, then again
It ferments 1-2 months, breathes freely weekly in fermentation process secondary, breathe freely four times altogether, bitter buckwheat fermentation material is made;Wherein, probiotics weight
The 0.1-0.5% of boiling bitter buckwheat kernel weight is accounted for, saccharomycete accounts for the 2-4% of boiling bitter buckwheat kernel weight, and distiller's yeast weight accounts for boiling
The 0.1-0.3% of bitter buckwheat kernel weight.
Further, bitter buckwheat seed is impregnated into 12h, then boiling 30min in water in step (2).
Further, buckwheat powder and water are 1:2 mixing by weight in step (3), and 3% buckwheat powder weight is then added
Saccharomycete mixes, in 30 DEG C of fermentation 2.5h.
Further, probiotics weight accounts for the 0.4% of boiling bitter buckwheat kernel weight in step (3), and saccharomycete accounts for boiling hardship
The 3% of buckwheat kernel weight, distiller's yeast weight account for the 0.2% of boiling bitter buckwheat kernel weight.
Further, probiotics is streptococcus thermophilus, Lactobacillus delbrueckii, lactobacillus plantarum and Bulgaria in step (3)
At least one of lactobacillus.
Further, probiotics is lactobacillus plantarum in step (3).
It is a kind of for preventing and treating the food or beverage of metabolic syndrome, one of ingredient or main component are hardship obtained above
Buckwheat fermentation material.
Provided by the present invention for prevent and treat the bitter buckwheat fermentation material of metabolic syndrome, the food or beverage comprising the fermentation material and
Preparation method has the advantages that
(1) growth of Aspergillus flavus is prevented
Aspergillus flavus easy to breed generates aflatoxins in turn to bitter buckwheat in process, and aflatoxins is that level-one is carcinogenic
Object, therefore must be strictly controlled in bitter buckwheat process the generation of aflatoxins.The present invention is by bitter buckwheat seed through being dried
So that moisture is reduced to 3-5%, or bitter buckwheat seed is passed through60The sterilizing of Co- gamma-ray irradiation.65-75 DEG C of drying process not only makes
Bitter buckwheat seed loses free moisture, still maintains outside original processing performance, can also inactivate rutin hydrolase, rutin cannot
Quercetin and rutin sophorin are hydrolyzed by rutin hydrolase;It can also make the rutin hydrolase in bitter buckwheat seed in irradiation process simultaneously
Equal protein inactivations, after rutin hydrolase inactivation would not hydrolyzing rutin, and then Quercetin will not be generated, Quercetin is Aspergillus flavus
The main source of energy and carbon metablism is the main substrate of Aspergillus flavus metabolism, if without Quercetin, so that it may be reduced yellow bent
The growth of mould.When the growth for inhibiting aspergillus flavus, bitter buckwheat seed can be stored and be transported, be stored up for its process
It is standby.
Aspergillus flavus belongs to aerobic bacteria, and strictly to limit oxygen can greatly increase processing cost.In bitter buckwheat seed activity at
/ mono- is rutin, and rutin hydrolytic process can generate Quercetin, and Quercetin is not only trophic function ingredient and Aspergillus flavus energy
The main source of amount and carbon metablism is the main substrate of Aspergillus flavus metabolism.Being hydrolyzed into Quercetin to limitation rutin can prevent
The only breeding of aspergillus flavus.After the present invention crushes bitter buckwheat seed, after saccharomycetes to make fermentation, rutin hydrolysate Quercetin can be turned
The absorbable phenol derivatives of human body is turned to, so that metabolism substrate cannot be provided for the breeding of Aspergillus flavus, also just further
Ground inhibits the growth of aspergillus flavus.
When the growth for inhibiting Aspergillus flavus, bitter buckwheat seed can be stored and be transported, be stored up for its process
It is standby.Although inhibiting rutin to be hydrolyzed to Quercetin in storage, transport and process, after edible bitter buckwheat product, bitter buckwheat
Rutin in product, which in human body alimentary canal can decompose, generates the Quercetin of specific trophic function, provides nutrition for human body.
(2) bitter taste of bitter buckwheat seed is reduced
There are bitter taste when bitter buckwheat is edible, bitter principle is mainly distributed in seed seed coat layer, but containing big in bitter buckwheat kind skin
The nutritional ingredient of amount.Therefore, the bitter substance in kind of skin need to be handled or is converted.Bitter substance in kind skin is mainly Mongolian oak
Pi Su, Quercetin are that rutin generates under the action of rutin hydrolase, therefore inhibits rutin hydrolase activity or Quercetin generation
Thanking and being converted into phenolic compound is the most effectual way for reducing bitter buckwheat bitter taste.The present invention is by bitter buckwheat seed through saccharomycete and lactic acid bacteria
After fermentation, Quercetin can be converted the derivative that adult body can be absorbed, effectively reduce the bitter taste of bitter buckwheat.
(3) change bitter buckwheat structure of dough
Glutelin is free of in bitter buckwheat, therefore cannot can improve structure of dough through saccharomycetes to make fermentation as wheat flour.
Bitter buckwheat after saccharomycetes to make fermentation, can be effectively improved bitter buckwheat structure of dough by the present invention, improve its mouthfeel, not add flour, paddy
Protein powder etc. can make bitter buckwheat effectively be fermented under conditions of containing glutelin ingredient, improve bitter buckwheat edible quality.
(4) bitter buckwheat is through probiotics fermention
When bitter buckwheat is used for beverage etc., bitter buckwheat seed need to be impregnated 4-20h in water, it is made to absorb enough water
Point, then energy boiling is well-done in a short time, when well-done bitter buckwheat seed and probiotics, saccharomycete, distiller's yeast and cold boiled water
Mixing is fermented, and it is organic that dietary fiber, polysaccharide in bitter buckwheat etc. can be decomposed under the action of probiotics, saccharomycete and distiller's yeast
Object generates the organic solvents such as organic acid and ethyl alcohol, forms acid organic environment, is conducive to the functional component such as Thunder God of poorly water-soluble
The dissolution of rattan red pigment, salicylamine (2- hydroxy benzylamine), after fermentation, liquid beverage, solid component can be made in liquid component
It can also be used to prepare solid beverage.
By bitter buckwheat through two kinds of fermentation methods, rutin, Quercetin, trypterygine are contained in finally obtained tunning
The function nutritions ingredients such as element, salicylamide and dietary fiber can prevent and treat hypertension, diabetes and fat this kind of Metabolic syndrome
Sign.
Detailed description of the invention
Fig. 1 is process flow chart of the invention.
Fig. 2 is loose porous structure figure of the buckwheat powder after saccharomycetes to make fermentation.
Specific embodiment
Embodiment 1
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
It (2) is 5% to water content in 65 DEG C of dryings by the bitter buckwheat seed selected, moisture content is low, and it is raw just to have lacked enzymatic
Changing reaction condition, the rutin in bitter buckwheat is difficult to be hydrolyzed into Quercetin and rutin sophorin by rutin hydrolase, bitter taste would not be generated,
Material conditions needed for also having lacked Aspergillus flavus growth simultaneously, and then inhibit the growth of Aspergillus flavus;
The step may be: the bitter buckwheat seed of selection is passed through60The sterilizing of Co- gamma-ray irradiation, can make in irradiation process
Rutin hydrolase inactivation needed for obtaining rutin hydrolysis.Bitter buckwheat seed can not be stored and be transported under the conditions of integral asepsis, irradiation
Aspergillus flavus can be inactivated, but still there is Aspergillus flavus in the environment, as long as there is the environmental condition of suitable Aspergillus flavus growth,
It will mass propagation generation aflatoxins;Therefore during irradiating rutin hydrolase is inactivated, rutin can not just be hydrolyzed into
Quercetin, Aspergillus flavus have just lacked material conditions necessary to growth, and growth will be suppressed;Quercetin can not generate,
Also the bitter taste in bitter buckwheat seed is just eliminated.
(3) the resulting bitter buckwheat seed of step (2) is ground into buckwheat powder, is by weight that 1:1 is mixed by buckwheat powder and water,
Then the Angel Yeast for adding 2% buckwheat powder weight mixes, and in 35 DEG C of fermentation 1h, obtains bitter buckwheat fermentation material.
Embodiment 2
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
It (2) is 3% to water content in 75 DEG C of dryings by the bitter buckwheat seed selected, moisture content is low, and it is raw just to have lacked enzymatic
Changing reaction condition, the rutin in bitter buckwheat is difficult to be hydrolyzed into Quercetin and rutin sophorin by rutin hydrolase, bitter taste would not be generated,
Material conditions needed for also having lacked Aspergillus flavus growth simultaneously, and then inhibit the growth of Aspergillus flavus;
(3) the resulting bitter buckwheat seed of step (2) is ground into buckwheat powder, is by weight that 1:3 is mixed by buckwheat powder and water,
Then the Angel Yeast for adding 4% buckwheat powder weight mixes, and in 25 DEG C of fermentation 3h, obtains bitter buckwheat fermentation material.
Embodiment 3
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
It (2) is 3% to water content in 70 DEG C of dryings by the bitter buckwheat seed selected, moisture content is low, and it is raw just to have lacked enzymatic
Changing reaction condition, the rutin in bitter buckwheat is difficult to be hydrolyzed into Quercetin and rutin sophorin by rutin hydrolase, bitter taste would not be generated,
Material conditions needed for also having lacked Aspergillus flavus growth simultaneously, and then inhibit the growth of Aspergillus flavus;
(3) the resulting bitter buckwheat seed of step (2) is ground into buckwheat powder, is by weight that 1:2 is mixed by buckwheat powder and water,
Then the Angel Yeast for adding 4% buckwheat powder weight mixes, and in 30 DEG C of fermentation 2.5h, obtains bitter buckwheat fermentation material.
By 3 gained bitter buckwheat fermentation material boiling 25-35min of embodiment, it is made bitter buckwheat food (bitter buckwheat fermentation cake).With this
Bitter buckwheat food made from method is because rutin can not be hydrolyzed into Quercetin before fermentation and in fermentation, therefore entrance does not have bitter taste;
The gas generated in fermentation process simultaneously is not escaped, and honeycomb structure is generated, loose porous (result is shown in Fig. 2), improves hardship
It the problem of buckwheat food poor taste, is easier to be received by broad masses.Therefore the present invention not only effectively reduces traditionally bitter buckwheat diet
With bitter taste, and bitter buckwheat is because being free of the unfermentable technical bottleneck of glutelin.
Embodiment 4
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
(2) by the bitter buckwheat seed selected 70 DEG C it is dry to water content be 3%, then impregnate in water, with steep rise without
It is broked into standard, then drains the moisture on bitter buckwheat seed surface, then boiling 30-40min, is subject to no hard-core, is finally cooled to room
Temperature obtains boiling bitter buckwheat seed;
(3) by the resulting boiling bitter buckwheat seed of step (2), lactobacillus plantarum, Angel Yeast bacterium, Angel distiller's yeast and cold boiled water
Mixing is sealed fermentation, and fermentation temperature is 35 DEG C, when fermentation to alcoholic strength reaches 3-5 degree (this fermentation process is primary fermentation)
Post-fermentation process is carried out, post-fermentation process is one and a half months, breathes freely 2 times weekly during primary fermentation, breathes freely 4 times altogether, rear to send out
Ferment process cannot at will open sealing cover;Wherein, lactobacillus plantarum weight accounts for the 0.1% of boiling bitter buckwheat kernel weight, Angel ferment
Female bacterium accounts for the 2% of boiling bitter buckwheat kernel weight, and Angel distiller's yeast weight accounts for the 0.1% of boiling bitter buckwheat kernel weight.
Embodiment 5
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
(2) by the bitter buckwheat seed selected 70 DEG C it is dry to water content be 3%, then impregnate in water, with steep rise without
It is broked into standard, then drains the moisture on bitter buckwheat seed surface, then boiling 30-40min, is subject to no hard-core, is finally cooled to room
Temperature obtains boiling bitter buckwheat seed;
(3) by the resulting boiling bitter buckwheat seed of step (2), lactobacillus plantarum, Angel Yeast bacterium, Angel distiller's yeast and cold boiled water
Mixing is sealed fermentation, and fermentation temperature is 15 DEG C, when fermentation to alcoholic strength reaches 3-5 degree (this fermentation process is primary fermentation)
Post-fermentation process is carried out, post-fermentation process is 2 months, it breathes freely 2 times weekly during primary fermentation, breathes freely 4 times altogether, post-fermentation process
Sealing cover cannot at will be opened;Wherein, lactobacillus plantarum weight accounts for the 0.5% of boiling bitter buckwheat kernel weight, and Angel Yeast bacterium accounts for
The 4% of boiling bitter buckwheat kernel weight, Angel distiller's yeast weight account for the 0.3% of boiling bitter buckwheat kernel weight.
Embodiment 6
It is a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, comprising the following steps:
(1) selection of raw material: bitter buckwheat full seed is uniform, no moth, and phenomenon of going rotten, inclusion rates are less than 1%, moisture content
≤ 8%, content of starch >=60%;
(2) by the bitter buckwheat seed selected 70 DEG C it is dry to water content be 3%, then impregnate in water, with steep rise without
It is broked into standard, then drains the moisture on bitter buckwheat seed surface, then boiling 30-40min, is subject to no hard-core, is finally cooled to room
Temperature obtains boiling bitter buckwheat seed;
(3) by the resulting boiling bitter buckwheat seed of step (2), lactobacillus plantarum, Angel Yeast bacterium, Angel distiller's yeast and cold boiled water
Mixing is sealed fermentation, and fermentation temperature is 30 DEG C, when fermentation to alcoholic strength reaches 3-5 degree (this fermentation process is primary fermentation)
Post-fermentation process is carried out, post-fermentation process is January, it breathes freely 2 times weekly during primary fermentation, breathes freely 4 times altogether, post-fermentation process
Sealing cover cannot at will be opened;Wherein, lactobacillus plantarum weight accounts for the 0.4% of boiling bitter buckwheat kernel weight, and Angel Yeast bacterium accounts for
The 3% of boiling bitter buckwheat kernel weight, Angel distiller's yeast weight account for the 0.2% of boiling bitter buckwheat kernel weight.
To by embodiment 4-6, after fermentation, separation is sealed by fermentation resulting fermented juice and vinasse respectively, to fermented juice and
Vinasse are sterilized, and are then proceeded as follows:
(1) it clarifies: clarification 48-72h being carried out to fermented juice with diatomite, obtains limpid, the liquid fermentate of no suspended substance;
(2) the liquid fermentate pH value after clarifying is 4.0-6.5, and 0.02% weight of liquid fermentation liquid is then added thereto
Citric acid, after high-temperature sterilization, bitter buckwheat fermented beverage is made, wherein lactic acid content >=1.0%.
Vinasse are handled as follows:
(1) vinasse are freezed into 20-24h under the conditions of -20~-25 DEG C, then vacuum refrigeration under the conditions of -18~-20 DEG C
Dry 12-14h, moisture content control are 3-5%;
(2) step (1) gains are ground step by step, successively obtain granularity be 500 μm of bitter buckwheat vinasse below,
200 μm of bitter buckwheat vinasse below, 100 μm of bitter buckwheat vinasse below, finally obtaining granularity is 10 μm of bitter buckwheat vinasse ultra micros below
Powder.
Bitter buckwheat vinasse Ultramicro-powder contains dietary fiber, multivitamin, microelement, rutin, Celastrol and bigcatkin willow
Bitter buckwheat Ultramicro-powder with bitter buckwheat fragrance is compounded with beverage ingredient, can be made into solid beverage, can make by the trophic functions ingredient such as amine
Beverage mouthfeel is more fine and smooth, and nutrition is richer.
Bitter buckwheat food obtained above is tested as follows:
1, zoopery
(1) animal and source: SPF grades of male spontaneous hypertensive rats (SHR), 300-350g are real purchased from Beijing animal
Test center.
(2) it is grouped: after male spontaneous hypertensive rat adaptable fed 7 days, 2 groups is randomly divided into, to compare for SPF grade
Group and experimental group, every group 5.
(3) experimental method
Control group: basal feed, basal feed ingredient are given are as follows: carbohydrate 64%, protein 21%, fat 4%,
Fiber 5%.
Experimental group: bitter buckwheat food (bitter buckwheat dough fermented food, that is, bitter buckwheat fermentation cake) produced by the present invention.
Rat in control group and experimental group carries out ad lib and drinking-water, and raising room temperature is 23 ± 2 DEG C, relatively wet
Degree is 55 ± 5%.Claim a weight weekly, survey a blood pressure weekly, in the evening before that day that experiment terminates, to Rat Fast
12h, then eye socket takes blood, and biochemistry detection blood sugar concentration, specific test result is as follows:
2, patient tests
(1) certain female, 59 years old, prehypertensive, prediabetes, before experiment, empty stomach/postprandial blood sugar was 6.1/
10.7mmol/L, blood pressure 135/85mmHg, weight 52kg continuously eat bitter buckwheat food one month produced by the present invention, daily
Morning 100g, noon and each 50g, weight 48kg, weight loss 7.69%, blood pressure and change of blood sugar are as follows at night:
After a week: blood glucose 6.1/10.3mmol/L, blood pressure 130/84mmHg.
After two weeks: blood glucose 5.5/9.8mmol/L, blood pressure 124/85mmHg.
After three weeks: blood glucose 5.7/8.6mmol/L, blood pressure 125/78mmHg.
After four weeks: blood glucose 5.3/8.2mmol/L, blood pressure 118/78mmHg.
(2) certain male, 67 years old, 10 years metabolism syndrome virus histories, before experiment, empty stomach/postprandial blood sugar was 8.5/12.3mmol/L,
Blood pressure is 151/99mmHg, weight 68kg, is continuously eaten bitter buckwheat food one month produced by the present invention, every morning 100g, in
Noon and evening each 50g, weight 62kg, weight loss 8.82%, blood pressure and change of blood sugar are as follows:
After a week: blood glucose 8.3/12.1mmol/L, blood pressure 151/99mmHg.
After two weeks: blood glucose 8.3/11.8mmol/L, blood pressure 150/96mmHg.
After three weeks: blood glucose 7.8/9.6mmol/L, blood pressure 145/95mmHg.
After four weeks: blood glucose 7.3/8.5mmol/L, blood pressure 140/91mmHg.
(3) certain male, 60 years old, 5 years metabolism syndrome virus histories, before experiment, empty stomach/postprandial blood sugar was 7.5/11.9mmol/L,
Blood pressure is 148/95mmHg, weight 68kg, is continuously eaten bitter buckwheat food one month produced by the present invention, every morning 100g, in
Noon and at night each 50g, weight 62kg, weight loss 8.82%, blood pressure and change of blood sugar are as follows:
After a week: blood glucose 7.5/11.5mmol/L, blood pressure 148/94mmHg.
After two weeks: blood glucose 7.3/10.6mmol/L, blood pressure 145/95mmHg.
After three weeks: blood glucose 6.9/9.1mmol/L, blood pressure 144/93mmHg.
After four weeks: blood glucose 6.6/7.9mmol/L, blood pressure 141/89mmHg.
Pass through Experimental comparison, it was confirmed that the effect of bitter buckwheat food produced by the present invention has blood pressure lowering, controls blood glucose and weight.
Claims (7)
1. a kind of for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which comprises the following steps:
(1) rutin hydrolase inactivates: it is 3-5% or warp that bitter buckwheat seed, which is dried at 65-75 DEG C to water content,60Co- gamma-rays spoke
According to sterilizing, inactivate rutin hydrolase;
(2) fermented pretreatment: bitter buckwheat seed obtained by step (1) is crushed, buckwheat powder is obtained;Or by bitter buckwheat obtained by step (1)
Seed drains surface moisture, then boiling 30-40min after impregnating 4-20h in water, is then dried in the air naturally to room temperature, obtains boiling bitter buckwheat
Seed;
(3) it ferments: being by weight that 1:1-3 is mixed by buckwheat powder and water, the saccharomycete of 2-4% buckwheat powder weight is then added,
It mixes, in 20-35 DEG C of fermentation 1-3h, bitter buckwheat fermentation material is made;Or by boiling bitter buckwheat seed, probiotics, saccharomycete, distiller's yeast and cool
It is white to open mixing, it is sealed fermentation, fermentation temperature is 15-35 DEG C, and first fermentation 2-4 weeks is 3-5 degree to alcoholic strength, is then fermented again
It 1-2 months, breathes freely weekly in fermentation process secondary, breathes freely four times altogether, bitter buckwheat fermentation material is made;Wherein, probiotics weight accounts for steaming
The 0.1-0.5% of bitter buckwheat kernel weight is boiled, saccharomycete accounts for the 2-4% of boiling bitter buckwheat kernel weight, and distiller's yeast weight accounts for boiling bitter buckwheat
The 0.1-0.3% of kernel weight.
2. according to claim 1 for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which is characterized in that
Bitter buckwheat seed is impregnated into 12h, then boiling 30min in water in step (2).
3. according to claim 1 for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which is characterized in that
Buckwheat powder and water are 1:2 mixing by weight in step (3), and the saccharomycete of 3% buckwheat powder weight is then added, and are mixed, 30
DEG C fermentation 2.5h.
4. according to claim 1 for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which is characterized in that
Probiotics weight accounts for the 0.4% of boiling bitter buckwheat kernel weight in step (3), and saccharomycete accounts for the 3% of boiling bitter buckwheat kernel weight, wine
Qu Chongliang accounts for the 0.2% of boiling bitter buckwheat kernel weight.
5. according to claim 1 for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which is characterized in that
Probiotics is at least one in streptococcus thermophilus, Lactobacillus delbrueckii, lactobacillus plantarum and lactobacillus bulgaricus in step (3)
Kind.
6. according to claim 5 for preventing and treating the preparation method of the bitter buckwheat fermentation material of metabolic syndrome, which is characterized in that
Probiotics is lactobacillus plantarum in step (3).
7. a kind of for preventing and treating the food or beverage of metabolic syndrome, which is characterized in that including described in claim any one of 1-6
Bitter buckwheat fermentation material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910585656.7A CN110250417A (en) | 2019-07-01 | 2019-07-01 | For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910585656.7A CN110250417A (en) | 2019-07-01 | 2019-07-01 | For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110250417A true CN110250417A (en) | 2019-09-20 |
Family
ID=67923645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910585656.7A Pending CN110250417A (en) | 2019-07-01 | 2019-07-01 | For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110250417A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110800915A (en) * | 2019-10-25 | 2020-02-18 | 周建军 | Food for relieving diabetes symptoms and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101294124A (en) * | 2008-06-17 | 2008-10-29 | 郝林 | Technique for preparing tartary buckwheat sweet fermented glutinous rice |
CN101856126A (en) * | 2010-06-22 | 2010-10-13 | 西昌航飞苦荞科技发展有限公司 | Fagopyrum tataricum food base stock, food or health-care food made by same and preparation method thereof |
CN103263484A (en) * | 2013-05-31 | 2013-08-28 | 四川师范大学 | Fermentation method and fermentation product of tartary buckwheat bran |
CN103627592A (en) * | 2013-12-12 | 2014-03-12 | 重庆禾金荞农产品有限公司 | Preparation method of tartary buckwheat yellow rice wine |
CN104054770A (en) * | 2014-07-09 | 2014-09-24 | 厦门大学 | Manufacturing method for tartary buckwheat baked food |
CN105238659A (en) * | 2015-11-17 | 2016-01-13 | 刘良贵 | Method for brewing buckwheat flavonoid wine |
CN106010852A (en) * | 2016-05-10 | 2016-10-12 | 贵州理工学院 | Tartary buckwheat kvass healthcare beverage and preparing method thereof |
CN107660670A (en) * | 2017-10-16 | 2018-02-06 | 山西省生物研究所 | Bitter buckwheat probiotics drink and preparation method thereof |
-
2019
- 2019-07-01 CN CN201910585656.7A patent/CN110250417A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101294124A (en) * | 2008-06-17 | 2008-10-29 | 郝林 | Technique for preparing tartary buckwheat sweet fermented glutinous rice |
CN101856126A (en) * | 2010-06-22 | 2010-10-13 | 西昌航飞苦荞科技发展有限公司 | Fagopyrum tataricum food base stock, food or health-care food made by same and preparation method thereof |
CN103263484A (en) * | 2013-05-31 | 2013-08-28 | 四川师范大学 | Fermentation method and fermentation product of tartary buckwheat bran |
CN103627592A (en) * | 2013-12-12 | 2014-03-12 | 重庆禾金荞农产品有限公司 | Preparation method of tartary buckwheat yellow rice wine |
CN104054770A (en) * | 2014-07-09 | 2014-09-24 | 厦门大学 | Manufacturing method for tartary buckwheat baked food |
CN105238659A (en) * | 2015-11-17 | 2016-01-13 | 刘良贵 | Method for brewing buckwheat flavonoid wine |
CN106010852A (en) * | 2016-05-10 | 2016-10-12 | 贵州理工学院 | Tartary buckwheat kvass healthcare beverage and preparing method thereof |
CN107660670A (en) * | 2017-10-16 | 2018-02-06 | 山西省生物研究所 | Bitter buckwheat probiotics drink and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110800915A (en) * | 2019-10-25 | 2020-02-18 | 周建军 | Food for relieving diabetes symptoms and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104522803B (en) | A kind of bitter-buckwheat embryo, oat germ composite fermented beverage and preparation method thereof | |
CN103773653B (en) | A kind of brewing method of hawthorn banana mulse | |
CN101926488B (en) | Preparation method of wild pawpaw fruit vinegar beverage | |
CN104621534B (en) | A kind of preparation method of soy sauce | |
CN103039927A (en) | Biologically fermented black purslane food and preparation method thereof | |
CN110973423A (en) | Red yeast noni beverage and preparation method thereof | |
KR20030082347A (en) | Process for preparing jujube wine | |
CN108041388A (en) | A kind of processing technology of non-alcoholic fermented grape beverage | |
CN110250417A (en) | For preventing and treating the bitter buckwheat fermentation material of metabolic syndrome, food or beverage and preparation method comprising the fermentation material | |
KR20140034981A (en) | Method for increasing resveratrol content of peanut sprouts and foods in resveratrol of peanut sprouts | |
CN107058049B (en) | Brewing method of agaricus bisporus vinegar | |
CN112251312A (en) | Preparation process of hawthorn wine | |
CN111235003B (en) | Pomegranate composite health-care fruit vinegar and preparation method thereof | |
US20240041072A1 (en) | Non-alcoholic functional beverage with a malt base or based on non-alcoholic beer or a water-aroma base enriched with amino acids and dietary fibre as well as a method of manufacturing a non-alcoholic functional beverage with a malt base or based on non-alcoholic beer or a water-aroma base, enriched with amino acids and dietary fibre | |
CN108504487A (en) | A kind of fermented glutinous rice and preparation method thereof with QI invigorating tonifying spleen effect | |
KR100767802B1 (en) | Functional beverage containing persimmon vinegar | |
CN109674002A (en) | A kind of pure-blood ferment rice acid soup preparation method | |
CN112899117A (en) | Method for co-fermenting high gamma-aminobutyric acid red date and pearl barley vinegar by combining monascus with lactobacillus and spore bacteria | |
EP2882280B1 (en) | Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions | |
US20210153537A1 (en) | Compound beverage containing corn peptides and pueraria root extract and preparation method thereof | |
CN112450346A (en) | Preparation method of sugar-free Piteguo fermented juice | |
CN111733038A (en) | Cistanche health-care wine and preparation method thereof | |
KR101144329B1 (en) | Vinegar using Rosa rugosa Thunb and Preparation method for the same | |
KR20020066801A (en) | Process for preparing wax gourd wine | |
CN109198341A (en) | Sweet Wine drink of a kind of purple rice fermentation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200312 Address after: 100020 middle street, Xiliu village, Sanjianfang Township, Chaoyang District, Beijing (2237 Sanjianfang animation central office area) Applicant after: Beijing haodingrui Health Technology Center (limited partnership) Address before: 610000 No.39 Xiaotianbei Street, Wuhou District, Chengdu City, Sichuan Province Applicant before: Chengdu Holes Biotechnology Co.,Ltd. |